These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 22986526)
21. DDX3, a DEAD box RNA helicase with tumor growth-suppressive property and transcriptional regulation activity of the p21waf1/cip1 promoter, is a candidate tumor suppressor. Chao CH; Chen CM; Cheng PL; Shih JW; Tsou AP; Lee YH Cancer Res; 2006 Jul; 66(13):6579-88. PubMed ID: 16818630 [TBL] [Abstract][Full Text] [Related]
22. Ribosomal protein S27-like, a p53-inducible modulator of cell fate in response to genotoxic stress. Li J; Tan J; Zhuang L; Banerjee B; Yang X; Chau JF; Lee PL; Hande MP; Li B; Yu Q Cancer Res; 2007 Dec; 67(23):11317-26. PubMed ID: 18056458 [TBL] [Abstract][Full Text] [Related]
23. E2F1-dependent pathways are involved in amonafide analogue 7-d-induced DNA damage, G2/M arrest, and apoptosis in p53-deficient K562 cells. Li Y; Shao J; Shen K; Xu Y; Liu J; Qian X J Cell Biochem; 2012 Oct; 113(10):3165-77. PubMed ID: 22593008 [TBL] [Abstract][Full Text] [Related]
24. FOXO target gene CTDSP2 regulates cell cycle progression through Ras and p21(Cip1/Waf1). Kloet DE; Polderman PE; Eijkelenboom A; Smits LM; van Triest MH; van den Berg MC; Groot Koerkamp MJ; van Leenen D; Lijnzaad P; Holstege FC; Burgering BM Biochem J; 2015 Jul; 469(2):289-98. PubMed ID: 25990325 [TBL] [Abstract][Full Text] [Related]
25. Defective p53 signaling in p53 wild-type tumors attenuates p21waf1 induction and cyclin B repression rendering them sensitive to Chk1 inhibitors that abrogate DNA damage-induced S and G2 arrest. Levesque AA; Fanous AA; Poh A; Eastman A Mol Cancer Ther; 2008 Feb; 7(2):252-62. PubMed ID: 18281511 [TBL] [Abstract][Full Text] [Related]
26. P53-dependent antiproliferative and pro-apoptotic effects of trichostatin A (TSA) in glioblastoma cells. Bajbouj K; Mawrin C; Hartig R; Schulze-Luehrmann J; Wilisch-Neumann A; Roessner A; Schneider-Stock R J Neurooncol; 2012 May; 107(3):503-16. PubMed ID: 22270849 [TBL] [Abstract][Full Text] [Related]
27. Regulation of p53 target gene expression by peptidylarginine deiminase 4. Li P; Yao H; Zhang Z; Li M; Luo Y; Thompson PR; Gilmour DS; Wang Y Mol Cell Biol; 2008 Aug; 28(15):4745-58. PubMed ID: 18505818 [TBL] [Abstract][Full Text] [Related]
28. p53 Binding to the p21 promoter is dependent on the nature of DNA damage. Hill R; Bodzak E; Blough MD; Lee PW Cell Cycle; 2008 Aug; 7(16):2535-43. PubMed ID: 18719376 [TBL] [Abstract][Full Text] [Related]
29. p53-Dependent p21-mediated growth arrest pre-empts and protects HCT116 cells from PUMA-mediated apoptosis induced by EGCG. Thakur VS; Ruhul Amin AR; Paul RK; Gupta K; Hastak K; Agarwal MK; Jackson MW; Wald DN; Mukhtar H; Agarwal ML Cancer Lett; 2010 Oct; 296(2):225-32. PubMed ID: 20444544 [TBL] [Abstract][Full Text] [Related]
30. PBK/TOPK interacts with the DBD domain of tumor suppressor p53 and modulates expression of transcriptional targets including p21. Hu F; Gartenhaus RB; Eichberg D; Liu Z; Fang HB; Rapoport AP Oncogene; 2010 Oct; 29(40):5464-74. PubMed ID: 20622899 [TBL] [Abstract][Full Text] [Related]
31. c-ABL tyrosine kinase modulates p53-dependent p21 induction and ensuing cell fate decision in response to DNA damage. Udden SM; Morita-Fujimura Y; Satake M; Ikawa S Cell Signal; 2014 Feb; 26(2):444-52. PubMed ID: 24177958 [TBL] [Abstract][Full Text] [Related]
32. Reexpression of hSNF5 in malignant rhabdoid tumor cell lines causes cell cycle arrest through a p21(CIP1/WAF1)-dependent mechanism. Kuwahara Y; Charboneau A; Knudsen ES; Weissman BE Cancer Res; 2010 Mar; 70(5):1854-65. PubMed ID: 20179200 [TBL] [Abstract][Full Text] [Related]
33. Involvement of RNA helicases p68 and p72 in colon cancer. Shin S; Rossow KL; Grande JP; Janknecht R Cancer Res; 2007 Aug; 67(16):7572-8. PubMed ID: 17699760 [TBL] [Abstract][Full Text] [Related]
34. Rap2b, a novel p53 target, regulates p53-mediated pro-survival function. Zhang X; He Y; Lee KH; Dubois W; Li Z; Wu X; Kovalchuk A; Zhang W; Huang J Cell Cycle; 2013 Apr; 12(8):1279-91. PubMed ID: 23535297 [TBL] [Abstract][Full Text] [Related]
35. LYG-202 inhibits the proliferation of human colorectal carcinoma HCT-116 cells through induction of G1/S cell cycle arrest and apoptosis via p53 and p21(WAF1/Cip1) expression. Liu W; Dai Q; Lu N; Wei L; Ha J; Rong J; Mu R; You Q; Li Z; Guo Q Biochem Cell Biol; 2011 Jun; 89(3):287-98. PubMed ID: 21491996 [TBL] [Abstract][Full Text] [Related]
36. Trichostatin A causes p53 to switch oxidative-damaged colorectal cancer cells from cell cycle arrest into apoptosis. Habold C; Poehlmann A; Bajbouj K; Hartig R; Korkmaz KS; Roessner A; Schneider-Stock R J Cell Mol Med; 2008 Apr; 12(2):607-21. PubMed ID: 18419600 [TBL] [Abstract][Full Text] [Related]
37. Combined loss of PUMA and p21 accelerates c-MYC-driven lymphoma development considerably less than loss of one allele of p53. Valente LJ; Grabow S; Vandenberg CJ; Strasser A; Janic A Oncogene; 2016 Jul; 35(29):3866-71. PubMed ID: 26640149 [TBL] [Abstract][Full Text] [Related]
38. Mechanisms of differential activation of target gene promoters by p53 hinge domain mutants with impaired apoptotic function. Kong XT; Gao H; Stanbridge EJ J Biol Chem; 2001 Aug; 276(35):32990-3000. PubMed ID: 11395510 [TBL] [Abstract][Full Text] [Related]
39. Gene-specific requirement for P-TEFb activity and RNA polymerase II phosphorylation within the p53 transcriptional program. Gomes NP; Bjerke G; Llorente B; Szostek SA; Emerson BM; Espinosa JM Genes Dev; 2006 Mar; 20(5):601-12. PubMed ID: 16510875 [TBL] [Abstract][Full Text] [Related]
40. Hypersensitivity to chromium-induced DNA damage correlates with constitutive deregulation of upstream p53 kinases in p21-/- HCT116 colon cancer cells. Hill R; Leidal AM; Madureira PA; Gillis LD; Cochrane HK; Waisman DM; Chiu A; Lee PW DNA Repair (Amst); 2008 Feb; 7(2):239-52. PubMed ID: 18024214 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]